The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...
A new study has found that the risk of serious bleeding is similar when taking the blood thinners apixaban and dabigatran compared to aspirin. However, the blood thinner rivaroxaban has a higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results